findmyKOL
Clinical trialNCT06868485RecruitingPhase 2Interventional

A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

SponsorWayshine Biopharm, Inc.Enrollment40Non Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Fujian Provincial Cancer Hospital

    Fuzhou, Fujian, China

    Recruiting
  • Wuhan Union Hospital

    Wuhan, Hubei, China

    Recruiting
  • Shanghai East Hospital

    Shanghai, Shanghai Municipality, China

    Recruiting
  • Shanghai Pulmonary Hospital

    Shanghai, Shanghai Municipality, China

    Recruiting
  • Tianjin Medical University Cancer Institute and Hospital

    Tianjin, Tianjin Municipality, China

    Recruiting
France
  • Centre Hospitalier Universitaire (chu) de Rennes - Hopital de Pontchaillou

    Rennes, Ille-et-Vilaine, France

    Recruiting
  • Centre Hospitalier Universitaire Chu de Limoges

    Limoges, New Aquitaine, France

    Recruiting
  • Chu Bordeaux - Centre Francois Magendie

    Pessac, New Aquitaine, France

    Recruiting
  • Centre Francois Baclesse

    Caen, Normandy, France

    Recruiting
  • Chu Toulon - Hopital Sainte Musse

    Toulon, Var, France

    Recruiting
United States
  • Fomat Oncology

    Oxnard, California, United States

    Recruiting
  • Cleveland Clinic Weston Hospital

    Weston, Florida, United States

    Recruiting
  • Karmanos Cancer Institute

    Detroit, Michigan, United States

    Recruiting
  • Hackensack Meridian Health-Southern Ocean Medical Center

    Manahawkin, New Jersey, United States

    Recruiting
  • Cleveland Clinic

    Cleveland, Ohio, United States

    Recruiting
  • Upmc Hillman Cancer Center

    Pittsburgh, Pennsylvania, United States

    Recruiting
  • Txo Central/south, Texas Oncology -Central/south Texas

    Austin, Texas, United States

    Recruiting
  • Virginia Cancer Specialists

    Fairfax, Virginia, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Aug 2025
Primary completion
30 Sept 2027
Completion
31 Dec 2027
Last update posted
8 Sept 2025
Registered enrollment
40
Registry id
NCT06868485

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.